Latest filing published 13 Oct 2026 for GSK plc, €23.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Mike Crichton discloses dealings in GSK plc to RNS (LSE). We count 10 filings; the first trade dates from 8 January 2026 and the latest from 8 October 2026.
Both buying and selling appear: 1 purchase, against 1 sale worth €99k. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants.
On 13 October 2026 came the latest disclosure, a share grant for €23 in GSK plc. The last insider purchase was made public on 13 January 2026, 284 days ago. Filings reach the RNS (LSE) feed a median of 4 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations